Smith Brendan has filed 3 insider transactions across 1 company since February 2023.
Most recent transaction: a option exercise of 3825 shares of CRISPR Therapeutics AG ($CRSP) on February 18, 2023.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2023 | CRISPR Therapeutics AG | $CRSP | Smith Brendan | Chief Financial Officer | M | Common Shares | 3825 | $0.00 | 6,464.0000 | 0 | 144.94% | 0.00% |
| Feb. 21, 2023 | CRISPR Therapeutics AG | $CRSP | Smith Brendan | Chief Financial Officer | F | Common Shares | 1392 | $48.26 | 5,072.0000 | 0 | 21.53% | 0.00% |
| Feb. 18, 2023 | CRISPR Therapeutics AG | $CRSP | Smith Brendan | Chief Financial Officer | M | Restricted Stock Units | 3825 | $0.00 | 11,475.0000 | 0 | 25.00% | 0.00% |